Skip to main content

Capital Cell — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

47
Companies
$105.0M
Total invested
$2.2M
Avg. check
21
Industries
Health Care 12Biotechnology 11Medical 8Health Diagnostics 7Pharmaceutical 6Medical Device 5+15 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 47
AbTx
September 2026

AbTx is a biotech firm developing next-generation antibody-drug conjugates with enzymatic precision for oncology.

Biopharma · Dijon$1.9M Seed
Biohope
May 2026

Biohope is dedicated to the development of diagnostic and therapeutic solutions for organ transplantation.

Biotechnology · MadridVenture - Series Unknown
DYNAMICS VR
March 2026

Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.

Information Technology · Seville$1.5M Seed
EVis Bioscience
February 2026

EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.

Genetics · Schlieren$873K Pre-Seed
EVerZom
October 2025

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.

Biotechnology · Paris$11.6M Series A
Oncostellae
September 2025

Oncostellae focuses on the discovery of new pharmaceutically active compounds and their development, from its initial phase

Health Diagnostics · Orense$330K Venture - Series Unknown
Aortyx
June 2025

The ultimate solution for aortic diseases

Biotechnology · Barcelona$16.0M Series A
MgShell
April 2025

MgShell manufactures intraocular devices for treating exudative form of age-related macular degeneration.

Health Care · Milan$1.3M Seed
MSInsight
March 2025

MSInsight bioinformatics start-up that develops diagnostic and treatment response prediction solutions for MSI cancers.

Biotechnology · Paris$1.7M Seed
Corify Care
December 2024

Corify Care is the developer of an innovative and completely non-invasive cardiac mapping system.

Health Care · Madrid$3.2M Venture - Series Unknown
OxyPrem
August 2024

OxyPrem is an advanced oxygen sensor that continuously monitors oxygen levels in the brains of high-risk preterm infants.

Health Care · Zürich$3.2M Equity Crowdfunding
Vytrus Biotech
May 2024

Vytrus Biotech was born as a spin-off company of the Faculty of Pharmacy at the University of Barcelona

Biotechnology · Barcelona$2.5M Venture - Series Unknown
Ability Pharmaceuticals
March 2024

Ability Pharmaceuticals is a drug discovery and development company.

Biotechnology · Barcelona$7.7M Venture - Series Unknown
Braingaze
March 2024

Braingaze develops mind tracking solutions that solve major challenges around cognitive disorders like ADHD and Mild Cognitive Impairment

Artificial Intelligence (AI) · Mataró$1.6M Venture - Series Unknown
MediQuo
February 2024

MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction.

Apps · BarcelonaVenture - Series Unknown
Affirma Biotech
February 2024

Affirma Biotech is a pre-clinical startup which develops host-directed drugs as treatments for chronic and infection diseases.

Biopharma · Barcelona$1.9M Venture - Series Unknown
Laminar Pharma
October 2023

Laminar Pharma is a biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.

Biotechnology · Palma De Mallorca$9.3M Venture - Series Unknown
Loop Dx
January 2023

In vitro diagnostic company that develops a rapid test for a faster sepsis diagnose through host immune system status.

Health Care · Barcelona$803K Seed
Exheus
November 2022

Exheus is provider of direct-to-consumer gene expression report that helps to optimise people’s health in a highly personalised way.

Health Care · Barcelona$671K Pre-Seed
Inrobics
August 2022

Inrobics proposes a rehabilitation model using artificial intelligence and social robots.

Artificial Intelligence (AI) · Madrid$355K Pre-Seed
MoWoot
March 2022

MOWOOT is a Non-pharmacological & Non-invasive solution for people suffering from chronic constipation.

Health Care · Barcelona$1.1M Series A
Kintsugi Therapeutics
November 2021

Kintsugi Therapeutics is a biopharmaceutical company that develops innovative therapies.

Biotechnology · Barcelona$1.1M Seed
FrontWave Imaging
September 2021

FrontWave Imaging is a developer of supercomputing software that helps with the diagnosis of breast cancer.

Biotechnology · Barcelona$879K Equity Crowdfunding

Where Capital Cell invests

Health Care12
Biotechnology11
Medical8
Health Diagnostics7
Pharmaceutical6
Medical Device5

About Capital Cell's portfolio

How many companies has Capital Cell invested in?▸

Capital Cell has invested in 47 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Capital Cell invest in?▸

Capital Cell's top investment sectors include Health Care, Biotechnology, Medical, Health Diagnostics, Pharmaceutical. The firm invests across 21 different industry categories.

What is Capital Cell's largest investment?▸

Among tracked funding rounds, Aortyx received $16.0M in a Series A round. Capital Cell's total known invested capital is $105.0M.

What is the average investment size for Capital Cell?▸

Capital Cell's average investment size is $2.2M across its portfolio of 47 companies.

What are Capital Cell's most recent investments?▸

Recent Capital Cell portfolio additions include AbTx, Biohope, DYNAMICS VR, EVis Bioscience, EVerZom. These companies were founded in 2020 or later.

Reach the founders behind these 47 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →